Merit Medical Systems, Inc. (MMSI): Price and Financial Metrics


Merit Medical Systems, Inc. (MMSI): $54.33

0.06 (+0.11%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

MMSI POWR Grades


  • Growth is the dimension where MMSI ranks best; there it ranks ahead of 95.7% of US stocks.
  • MMSI's strongest trending metric is Quality; it's been moving up over the last 179 days.
  • MMSI's current lowest rank is in the Momentum metric (where it is better than 19.56% of US stocks).

MMSI Stock Summary

  • With a price/earnings ratio of 76.38, Merit Medical Systems Inc P/E ratio is greater than that of about 90.8% of stocks in our set with positive earnings.
  • With a year-over-year growth in debt of -27.59%, Merit Medical Systems Inc's debt growth rate surpasses only 14.88% of about US stocks.
  • Over the past twelve months, MMSI has reported earnings growth of -1,928.17%, putting it ahead of merely 1.02% of US stocks in our set.
  • Stocks with similar financial metrics, market capitalization, and price volatility to Merit Medical Systems Inc are INTT, PLPC, ALOT, BC, and SSD.
  • MMSI's SEC filings can be seen here. And to visit Merit Medical Systems Inc's official web site, go to www.merit.com.

MMSI Valuation Summary

  • MMSI's price/sales ratio is 3.9; this is 65.64% lower than that of the median Healthcare stock.
  • Over the past 243 months, MMSI's price/sales ratio has gone up 2.4.
  • Over the past 243 months, MMSI's price/sales ratio has gone up 2.4.

Below are key valuation metrics over time for MMSI.

Stock Date P/S P/B P/E EV/EBIT
MMSI 2021-08-31 3.9 4.1 143.0 115.2
MMSI 2021-08-30 3.9 4.1 142.5 114.8
MMSI 2021-08-27 3.9 4.1 142.8 115.0
MMSI 2021-08-26 3.7 3.9 136.8 110.5
MMSI 2021-08-25 3.8 3.9 138.4 111.7
MMSI 2021-08-24 3.9 4.0 140.7 113.5

MMSI Growth Metrics

    Its 5 year cash and equivalents growth rate is now at 870.17%.
  • Its 4 year net income to common stockholders growth rate is now at -116.96%.
  • The 3 year net income to common stockholders growth rate now stands at 86.88%.
Over the past 49 months, MMSI's revenue has gone up $359,593,000.

The table below shows MMSI's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2021-09-30 1,054.263 138.331 43.219
2021-06-30 1,031.217 168.494 28.243
2021-03-31 969.263 171.638 4.269
2020-12-31 963.875 165.27 -9.843
2020-09-30 963.793 155.264 -29.426
2020-06-30 962.867 115.339 -29.815

MMSI's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • MMSI has a Quality Grade of C, ranking ahead of 57.58% of graded US stocks.
  • MMSI's asset turnover comes in at 0.622 -- ranking 67th of 186 Medical Equipment stocks.
  • OSUR, CNMD, and ESMC are the stocks whose asset turnover ratios are most correlated with MMSI.

The table below shows MMSI's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.622 0.436 0.033
2021-03-31 0.578 0.422 0.008
2020-12-31 0.567 0.416 -0.003
2020-09-30 0.559 0.417 -0.018
2020-06-30 0.551 0.419 -0.019
2020-03-31 0.571 0.432 0.005

MMSI Price Target

For more insight on analysts targets of MMSI, see our MMSI price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $76.22 Average Broker Recommendation 1.44 (Moderate Buy)

MMSI Stock Price Chart Interactive Chart >

Price chart for MMSI

MMSI Price/Volume Stats

Current price $54.33 52-week high $73.85
Prev. close $54.27 52-week low $51.31
Day low $53.95 Volume 115,676
Day high $55.02 Avg. volume 356,910
50-day MA $59.19 Dividend yield N/A
200-day MA $63.23 Market Cap 3.08B

Merit Medical Systems, Inc. (MMSI) Company Bio


Merit Medical Systems is engaged in the development, manufacture and distribution of proprietary disposable medical devices used in interventional and diagnostic procedures, particularly in cardiology, radiology and endoscopy. The company was founded in 1987 and is based in South Jordan, Utah.


MMSI Latest News Stream


Event/Time News Detail
Loading, please wait...

MMSI Latest Social Stream


Loading social stream, please wait...

View Full MMSI Social Stream

Latest MMSI News From Around the Web

Below are the latest news stories about Merit Medical Systems Inc that investors may wish to consider to help them evaluate MMSI as an investment opportunity.

Merit Medical Reports Results for Fourth Quarter and Year Ended December 31, 2021, Issues FY 2022 Guidance

Q4 2021 reported revenue of $278.5 million, up 7.9% on a reported basis and up 8.4% on a constant currency revenue, organic* basis, compared to Q4 2020Q4 2021 GAAP EPS increased 32% year-over-year to $0.36, compared to $0.27 in Q4 2020Q4 2021 non-GAAP EPS* increased 31% year-over-year to $0.71, compared to $0.54 in Q4 2020FY21 reported revenue of $1.075 billion, up 11.5% on a reported basis and up 10.4% on a constant currency revenue, organic* basis, compared to FY20FY21 GAAP EPS was $0.84, comp

Yahoo | February 24, 2022

Earnings Preview: Merit Medical (MMSI) Q4 Earnings Expected to Decline

Merit Medical (MMSI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Yahoo | February 17, 2022

LabCorp (LH) Q4 Earnings and Revenues Beat Estimates

LabCorp (LH) delivered earnings and revenue surprises of 14.75% and 2.95%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

Yahoo | February 10, 2022

McKesson (MCK) Q3 Earnings and Revenues Top Estimates

McKesson (MCK) delivered earnings and revenue surprises of 14.31% and 3.18%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

Yahoo | February 2, 2022

Here's Why You Should Retain Merit Medical (MMSI) Stock For Now

Investors continue to be optimistic about Merit Medical (MMSI) owing to its progress in the WAVE study and a strong product portfolio.

Yahoo | February 2, 2022

Read More 'MMSI' Stories Here

MMSI Price Returns

1-mo -11.20%
3-mo -20.15%
6-mo -12.79%
1-year -15.83%
3-year -5.86%
5-year 42.41%
YTD -12.79%
2021 12.23%
2020 77.80%
2019 -44.06%
2018 29.19%
2017 63.02%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.6568 seconds.